Cargando…
Adherence to Oral and Topical Medications in Cutaneous Lupus Erythematosus is not Well Characterized
INTRODUCTION: Treatment adherence plays a large role in chronic dermatologic diseases and may play an important role in the outcomes of patients with cutaneous lupus erythematosus (CLE). We sought to gauge what is currently known about adherence to topical and oral medications in patients with CLE....
Autores principales: | Farhangian, Michael E., Huang, William W., Feldman, Steven R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470959/ https://www.ncbi.nlm.nih.gov/pubmed/25899142 http://dx.doi.org/10.1007/s13555-015-0075-4 |
Ejemplares similares
-
Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
por: Sticherling, Michael
Publicado: (2011) -
Topical drug-induced subacute cutaneous lupus erythematosus isolated to the hands
por: Ramachandran, Sarika M, et al.
Publicado: (2017) -
Terbinafine-induced subacute cutaneous lupus erythematosus in two patients with systemic lupus erythematosus successfully treated with topical corticosteroids
por: Kalińska-Bienias, Agnieszka, et al.
Publicado: (2013) -
Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult
por: Mao, Qiu-Xia, et al.
Publicado: (2017) -
Cutaneous lupus erythematosus: An update
por: Grönhagen, Carina M, et al.
Publicado: (2014)